Bile inhibits release of cholecystokinin and neurotensin

Guillermo Gomez, F. Lluis, Y. S. Guo, G. H. Greeley, Courtney Townsend, J. C. Thompson

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

We have investigated the effect of bile on fat-stimulated release and basal plasma levels of cholecystokinin-33/39 (CCK) and neurotensin in six awake dogs prepared with chronic gastric and duodenal cannulas. Experimental bile diversion was achieved by catheterization of the common bile duct through the duodenal cannula; the gallbladder was undisturbed. Bile diversion significantly enhanced the release of both CCK and neurotensin that was stimulated by intraduodenal (ID) infusion of a triglyceride suspension (corn oil) (0.5 gm/kg-hr). The integrated release with ID triglyceride (ng [0 to 90 min]/ml) for CCK was control 5.58 ± 0.83, bile diversion 14.47 ± 2.81, bile excess 1.68 ± 0.56, and for neurotensin was control 0.35 ± 0.19, bile diversion 1.26 ± 0.35, and bile excess 0.45 ± 0.31. ID infusion of excessive bile (bile collected during bile diversion) significantly inhibited both the release and basal levels of CCK. Bile diversion alone did not modify plasma levels of CCK or neurotensin. We conclude that: (1) endogenous bile exerts a negative feedback effect on release of CCK and neurotensin induced by triglyceride and on basal plasma levels of CCK; (2) bile is unnecessary for the stimulation of endocrine cells in the intestinal mucosa by dietary fat; and (3) measured basal levels of CCK and neurotensin represent a real amount of circulating peptide in the fasting state, that is, the basal levels are real and not artifactual.

Original languageEnglish (US)
Pages (from-to)363-368
Number of pages6
JournalSurgery
Volume100
Issue number2
StatePublished - 1986

Fingerprint

Neurotensin
Cholecystokinin
Bile
Triglycerides
Corn Oil
Endocrine Cells
cholecystokinin 39
Dietary Fats
Common Bile Duct
Intestinal Mucosa
Gallbladder
Catheterization
Fasting
Stomach
Suspensions

ASJC Scopus subject areas

  • Surgery

Cite this

Gomez, G., Lluis, F., Guo, Y. S., Greeley, G. H., Townsend, C., & Thompson, J. C. (1986). Bile inhibits release of cholecystokinin and neurotensin. Surgery, 100(2), 363-368.

Bile inhibits release of cholecystokinin and neurotensin. / Gomez, Guillermo; Lluis, F.; Guo, Y. S.; Greeley, G. H.; Townsend, Courtney; Thompson, J. C.

In: Surgery, Vol. 100, No. 2, 1986, p. 363-368.

Research output: Contribution to journalArticle

Gomez, G, Lluis, F, Guo, YS, Greeley, GH, Townsend, C & Thompson, JC 1986, 'Bile inhibits release of cholecystokinin and neurotensin', Surgery, vol. 100, no. 2, pp. 363-368.
Gomez G, Lluis F, Guo YS, Greeley GH, Townsend C, Thompson JC. Bile inhibits release of cholecystokinin and neurotensin. Surgery. 1986;100(2):363-368.
Gomez, Guillermo ; Lluis, F. ; Guo, Y. S. ; Greeley, G. H. ; Townsend, Courtney ; Thompson, J. C. / Bile inhibits release of cholecystokinin and neurotensin. In: Surgery. 1986 ; Vol. 100, No. 2. pp. 363-368.
@article{67a6e44474a84c30a51a30dba01673d3,
title = "Bile inhibits release of cholecystokinin and neurotensin",
abstract = "We have investigated the effect of bile on fat-stimulated release and basal plasma levels of cholecystokinin-33/39 (CCK) and neurotensin in six awake dogs prepared with chronic gastric and duodenal cannulas. Experimental bile diversion was achieved by catheterization of the common bile duct through the duodenal cannula; the gallbladder was undisturbed. Bile diversion significantly enhanced the release of both CCK and neurotensin that was stimulated by intraduodenal (ID) infusion of a triglyceride suspension (corn oil) (0.5 gm/kg-hr). The integrated release with ID triglyceride (ng [0 to 90 min]/ml) for CCK was control 5.58 ± 0.83, bile diversion 14.47 ± 2.81, bile excess 1.68 ± 0.56, and for neurotensin was control 0.35 ± 0.19, bile diversion 1.26 ± 0.35, and bile excess 0.45 ± 0.31. ID infusion of excessive bile (bile collected during bile diversion) significantly inhibited both the release and basal levels of CCK. Bile diversion alone did not modify plasma levels of CCK or neurotensin. We conclude that: (1) endogenous bile exerts a negative feedback effect on release of CCK and neurotensin induced by triglyceride and on basal plasma levels of CCK; (2) bile is unnecessary for the stimulation of endocrine cells in the intestinal mucosa by dietary fat; and (3) measured basal levels of CCK and neurotensin represent a real amount of circulating peptide in the fasting state, that is, the basal levels are real and not artifactual.",
author = "Guillermo Gomez and F. Lluis and Guo, {Y. S.} and Greeley, {G. H.} and Courtney Townsend and Thompson, {J. C.}",
year = "1986",
language = "English (US)",
volume = "100",
pages = "363--368",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Bile inhibits release of cholecystokinin and neurotensin

AU - Gomez, Guillermo

AU - Lluis, F.

AU - Guo, Y. S.

AU - Greeley, G. H.

AU - Townsend, Courtney

AU - Thompson, J. C.

PY - 1986

Y1 - 1986

N2 - We have investigated the effect of bile on fat-stimulated release and basal plasma levels of cholecystokinin-33/39 (CCK) and neurotensin in six awake dogs prepared with chronic gastric and duodenal cannulas. Experimental bile diversion was achieved by catheterization of the common bile duct through the duodenal cannula; the gallbladder was undisturbed. Bile diversion significantly enhanced the release of both CCK and neurotensin that was stimulated by intraduodenal (ID) infusion of a triglyceride suspension (corn oil) (0.5 gm/kg-hr). The integrated release with ID triglyceride (ng [0 to 90 min]/ml) for CCK was control 5.58 ± 0.83, bile diversion 14.47 ± 2.81, bile excess 1.68 ± 0.56, and for neurotensin was control 0.35 ± 0.19, bile diversion 1.26 ± 0.35, and bile excess 0.45 ± 0.31. ID infusion of excessive bile (bile collected during bile diversion) significantly inhibited both the release and basal levels of CCK. Bile diversion alone did not modify plasma levels of CCK or neurotensin. We conclude that: (1) endogenous bile exerts a negative feedback effect on release of CCK and neurotensin induced by triglyceride and on basal plasma levels of CCK; (2) bile is unnecessary for the stimulation of endocrine cells in the intestinal mucosa by dietary fat; and (3) measured basal levels of CCK and neurotensin represent a real amount of circulating peptide in the fasting state, that is, the basal levels are real and not artifactual.

AB - We have investigated the effect of bile on fat-stimulated release and basal plasma levels of cholecystokinin-33/39 (CCK) and neurotensin in six awake dogs prepared with chronic gastric and duodenal cannulas. Experimental bile diversion was achieved by catheterization of the common bile duct through the duodenal cannula; the gallbladder was undisturbed. Bile diversion significantly enhanced the release of both CCK and neurotensin that was stimulated by intraduodenal (ID) infusion of a triglyceride suspension (corn oil) (0.5 gm/kg-hr). The integrated release with ID triglyceride (ng [0 to 90 min]/ml) for CCK was control 5.58 ± 0.83, bile diversion 14.47 ± 2.81, bile excess 1.68 ± 0.56, and for neurotensin was control 0.35 ± 0.19, bile diversion 1.26 ± 0.35, and bile excess 0.45 ± 0.31. ID infusion of excessive bile (bile collected during bile diversion) significantly inhibited both the release and basal levels of CCK. Bile diversion alone did not modify plasma levels of CCK or neurotensin. We conclude that: (1) endogenous bile exerts a negative feedback effect on release of CCK and neurotensin induced by triglyceride and on basal plasma levels of CCK; (2) bile is unnecessary for the stimulation of endocrine cells in the intestinal mucosa by dietary fat; and (3) measured basal levels of CCK and neurotensin represent a real amount of circulating peptide in the fasting state, that is, the basal levels are real and not artifactual.

UR - http://www.scopus.com/inward/record.url?scp=0022551005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022551005&partnerID=8YFLogxK

M3 - Article

VL - 100

SP - 363

EP - 368

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 2

ER -